For the quarter ending 2026-03-31, ARTL has $12,518K in assets. $5,846K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 10,273 | 600 | 1,720 | 2,066 |
| Prepaid expenses and other current assets | 148 | 95 | 107 | 167 |
| Total current assets | 10,421 | 695 | 1,827 | 2,233 |
| Operating lease right-of-use assets | 55 | 64 | 73 | 82 |
| Digital assets | - | - | 325 | - |
| Intangible asset | 2,039 | 2,039 | 2,039 | 2,039 |
| Other assets | 3 | 3 | 3 | 3 |
| Total assets | 12,518 | 2,801 | 4,267 | 4,357 |
| Accounts payable and accrued liabilities | 4,041 | 3,035 | 3,868 | 4,841 |
| Due to related parties | 468 | 345 | 32 | 26 |
| Operating lease liabilities - current portion | 41 | 40 | 39 | 36 |
| Convertible notes | - | - | - | 791 |
| Accrued interest - convertible notes | 26 | 11 | 46 | 18 |
| Accrued interest - convertible notes - related party | 10 | 4 | - | - |
| Convertible notes | 470 | 437 | 875 | - |
| Convertible notes - related party | 190 | 172 | - | - |
| Derivative liability | 582 | - | - | - |
| Total current liabilities | 5,828 | 4,044 | 4,860 | 5,712 |
| Operating lease liabilities | 18 | 29 | 40 | 51 |
| Total liabilities | 5,846 | 4,073 | 4,900 | 5,763 |
| Common stock, par value 0.001, 166,666,667 shares authorized and 876,032 and 673,008 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively | 1 | 2 | 2 | 1 |
| Additional paid-in capital | 72,890 | 62,013 | 58,491 | 54,617 |
| Accumulated deficit | -65,973 | -63,015 | -58,849 | -55,729 |
| Accumulated other comprehensive loss | -246 | -272 | -277 | -295 |
| Total stockholders' equity(deficit) | 6,672 | -1,272 | -633 | -1,406 |
| Total liabilities and stockholders' equity | 12,518 | 2,801 | 4,267 | 4,357 |
ARTELO BIOSCIENCES, INC. (ARTL)
ARTELO BIOSCIENCES, INC. (ARTL)